YU78001A - 6-(((aryland heteroaryl)oxy)methyl) naphthalene-2- carboximidamide derivatives, preparation and therapeutic application thereof - Google Patents
6-(((aryland heteroaryl)oxy)methyl) naphthalene-2- carboximidamide derivatives, preparation and therapeutic application thereofInfo
- Publication number
- YU78001A YU78001A YU78001A YUP78001A YU78001A YU 78001 A YU78001 A YU 78001A YU 78001 A YU78001 A YU 78001A YU P78001 A YUP78001 A YU P78001A YU 78001 A YU78001 A YU 78001A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- group
- preparation
- aryland
- oxy
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
- C07C311/27—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/31—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
- C07C311/35—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
- C07D213/34—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
Abstract
Pronalazak se odnosi na jedinjenja opšte formule (I) gde R1 predstavlja bilo atom vodonika, bilo amino grupu, bilo (C1-C4) alkil grupu, bilo (C1-C6) alkoksikarbonil grupu, bilo -OH grupu, R2 predstavlja bilo (C1-C6) alkil, bilo fenil ili benzil grupu bilo -CH2Q grupu, gde Q je heterociklična grupa; R3 i R5, na primer, predstavljaju nezavisno svaki od onog drugog bilo atom vodonika, bilo (C1-C4) alkil grupu, bilo -COOH grupu, bilo hidroksilnu grupu; R4 predstavlja bilo atom vodonika, bilo (C1-C4)alkil grupu, bilo -(CH2)p-COOR8 grupu; Z predstavlja bilo -CH- grupu, bilo atom azota. Pronalazak se takodje odnosi na postupke za dobijanje i terapeutsku primenu pomenutih jedinjenja.The invention relates to compounds of general formula (I) wherein R 1 represents either a hydrogen atom, or an amino group, or a (C 1 -C 4) alkyl group, or a (C 1 -C 6) alkoxycarbonyl group, or an -OH group, R 2 represents either C6) an alkyl, either a phenyl or benzyl group or a -CH2Q group, wherein Q is a heterocyclic group; R3 and R5, for example, represent independently of one another either a hydrogen atom, or a (C1-C4) alkyl group, or a -COOH group, or a hydroxyl group; R4 represents either a hydrogen atom, or a (C1-C4) alkyl group, or a - (CH2) p-COOR8 group; Z represents either a -CH- group or a nitrogen atom. The invention also relates to methods for the preparation and therapeutic use of said compounds.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905632A FR2793247B1 (en) | 1999-05-04 | 1999-05-04 | DERIVATIVES OF 6 - [[(ARYL AND HETEROARYL) OXY] METHYL] NAPHTALENE-2- CARBOXIMIDAMIDE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
Publications (1)
Publication Number | Publication Date |
---|---|
YU78001A true YU78001A (en) | 2004-07-15 |
Family
ID=9545179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU78001A YU78001A (en) | 1999-05-04 | 2000-04-25 | 6-(((aryland heteroaryl)oxy)methyl) naphthalene-2- carboximidamide derivatives, preparation and therapeutic application thereof |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1177169A1 (en) |
JP (1) | JP2002543176A (en) |
KR (1) | KR20020010634A (en) |
CN (1) | CN1359373A (en) |
AU (1) | AU4303700A (en) |
BG (1) | BG106048A (en) |
BR (1) | BR0010230A (en) |
CA (1) | CA2371284A1 (en) |
CZ (1) | CZ20013959A3 (en) |
EE (1) | EE200100579A (en) |
FR (1) | FR2793247B1 (en) |
HK (1) | HK1042288A1 (en) |
HU (1) | HUP0200893A3 (en) |
IL (1) | IL146107A0 (en) |
IS (1) | IS6121A (en) |
MX (1) | MXPA01011180A (en) |
NO (1) | NO20015387L (en) |
PL (1) | PL356122A1 (en) |
SK (1) | SK15932001A3 (en) |
TR (1) | TR200103215T2 (en) |
WO (1) | WO2000066545A1 (en) |
YU (1) | YU78001A (en) |
ZA (1) | ZA200108758B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4209659B2 (en) | 2001-11-15 | 2009-01-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Amidino derivative and anticoagulant and thrombosis therapeutic agent using the same |
US7217794B2 (en) | 2003-04-02 | 2007-05-15 | Daiamed, Inc. | Compounds and methods for treatment of thrombosis |
RS52030B (en) | 2006-03-24 | 2012-04-30 | Eisai R&D Management Co., Ltd. | Triazolone derivative |
WO2009038157A1 (en) * | 2007-09-21 | 2009-03-26 | Eisai R & D Management Co., Ltd. | 2,3-dihydroiminoisoindole derivative |
TW201206905A (en) | 2010-05-20 | 2012-02-16 | Eisai R & Amp D Man Co Ltd | Prodrug of triazolone compound |
CN109438272A (en) * | 2018-11-16 | 2019-03-08 | 常州大学 | The synthetic method of C5a receptor antagonist W-54011 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA928276B (en) * | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
JP3388803B2 (en) * | 1993-05-20 | 2003-03-24 | 第一製薬株式会社 | Method for producing optically active 7-amidinonaphthalene derivative |
PT798295E (en) * | 1994-12-02 | 2003-07-31 | Yamanouchi Pharma Co Ltd | NEW AMIDINONEFTILO DERIVATIVES OR SALT OF THIS |
-
1999
- 1999-05-04 FR FR9905632A patent/FR2793247B1/en not_active Expired - Fee Related
-
2000
- 2000-04-25 IL IL14610700A patent/IL146107A0/en unknown
- 2000-04-25 AU AU43037/00A patent/AU4303700A/en not_active Abandoned
- 2000-04-25 EP EP00922738A patent/EP1177169A1/en not_active Withdrawn
- 2000-04-25 CZ CZ20013959A patent/CZ20013959A3/en unknown
- 2000-04-25 PL PL00356122A patent/PL356122A1/en not_active Application Discontinuation
- 2000-04-25 KR KR1020017014068A patent/KR20020010634A/en not_active Application Discontinuation
- 2000-04-25 YU YU78001A patent/YU78001A/en unknown
- 2000-04-25 CN CN00809874A patent/CN1359373A/en active Pending
- 2000-04-25 JP JP2000615376A patent/JP2002543176A/en not_active Withdrawn
- 2000-04-25 CA CA002371284A patent/CA2371284A1/en not_active Abandoned
- 2000-04-25 SK SK1593-2001A patent/SK15932001A3/en unknown
- 2000-04-25 MX MXPA01011180A patent/MXPA01011180A/en unknown
- 2000-04-25 EE EEP200100579A patent/EE200100579A/en unknown
- 2000-04-25 TR TR2001/03215T patent/TR200103215T2/en unknown
- 2000-04-25 WO PCT/FR2000/001087 patent/WO2000066545A1/en not_active Application Discontinuation
- 2000-04-25 BR BR0010230-0A patent/BR0010230A/en not_active Application Discontinuation
- 2000-04-25 HU HU0200893A patent/HUP0200893A3/en unknown
-
2001
- 2001-10-23 IS IS6121A patent/IS6121A/en unknown
- 2001-10-24 ZA ZA200108758A patent/ZA200108758B/en unknown
- 2001-10-24 BG BG106048A patent/BG106048A/en unknown
- 2001-11-02 NO NO20015387A patent/NO20015387L/en not_active Application Discontinuation
-
2002
- 2002-05-14 HK HK02103641.5A patent/HK1042288A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO20015387D0 (en) | 2001-11-02 |
EE200100579A (en) | 2003-02-17 |
EP1177169A1 (en) | 2002-02-06 |
IS6121A (en) | 2001-10-23 |
CA2371284A1 (en) | 2000-11-09 |
SK15932001A3 (en) | 2002-04-04 |
CZ20013959A3 (en) | 2002-02-13 |
AU4303700A (en) | 2000-11-17 |
CN1359373A (en) | 2002-07-17 |
ZA200108758B (en) | 2002-10-24 |
TR200103215T2 (en) | 2002-07-22 |
MXPA01011180A (en) | 2002-04-24 |
BR0010230A (en) | 2002-02-13 |
WO2000066545A1 (en) | 2000-11-09 |
PL356122A1 (en) | 2004-06-14 |
FR2793247A1 (en) | 2000-11-10 |
JP2002543176A (en) | 2002-12-17 |
HUP0200893A2 (en) | 2002-07-29 |
FR2793247B1 (en) | 2001-06-22 |
NO20015387L (en) | 2002-01-07 |
HK1042288A1 (en) | 2002-08-09 |
HUP0200893A3 (en) | 2002-11-28 |
IL146107A0 (en) | 2002-07-25 |
BG106048A (en) | 2002-05-31 |
KR20020010634A (en) | 2002-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20040429B1 (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
RS50519B (en) | Substituted 8'pyri(mi)dinyl-dihydrospiro-/cycloalkylamine/ -pyrimido/1,2-a/pyrimidin-6-one derivatives | |
HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
NO2015020I2 (en) | Ceritinib or a pharmaceutically acceptable salt thereof | |
ATE241617T1 (en) | PYRIMIDINE COMPOUNDS | |
CO5050332A1 (en) | FUNGICIDE COMPOSITIONS THAT INCLUDE 2-METOXIBENZOPHENONES | |
NO20013379L (en) | 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents | |
YU34796A (en) | Substituted n-(indole-2-carbonyl)-î²alaninamides, derivatives thereof and pharmaceutical compositions containing them | |
HUP0400321A2 (en) | Fluoropyrrolidines as dipeptidyl peptidase inhibitors and pharmaceutical compositions containing them | |
WO2001077107A8 (en) | Oxazole derivatives and their uses as tyrosine kinase inhibitors | |
HUP0300350A2 (en) | Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof | |
ATE319446T1 (en) | NEW PROLINE COMPOUNDS AS MICROBICIDAL AGENTS | |
TW200607808A (en) | Pyrido-pyrimidine derivatives, preparation thereof and application thereof | |
HUP0300909A2 (en) | 2-guanidino-4-arylchinazolines as nhe-3 inhibitors, pharmaceutical compositions containing them and their use | |
MEP24208A (en) | Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics | |
NO20022125L (en) | Pyrrole derivatives as inhibitors of phosphodiesterase VII | |
YU46787B (en) | HETEROARYL 3-OXO-PROPANE-NITRILE DERIVATIVES AND PROCESS FOR THEIR OBTAINING | |
DE69925472D1 (en) | BENZOHETEROCYCLIC DISTAMYCINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS ANTITUMUM AGENT | |
HUP0302193A2 (en) | 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation thereof and pharmaceutical compositions containing them | |
RS51126B (en) | Process for the preparation of mesylates of piperazine derivatives | |
YU78001A (en) | 6-(((aryland heteroaryl)oxy)methyl) naphthalene-2- carboximidamide derivatives, preparation and therapeutic application thereof | |
RS50432B (en) | Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same | |
YU52498A (en) | USE OF 2-ARYLBENZEN (b) THIOPHENE FOR MEDICAMENT PREPARATION | |
HUP0004317A2 (en) | 5-ht1f agonists | |
RS49829B (en) | Process and intermediates for the manufactdre of pyridine-2,3- dicarboxylate compounds |